Anxu Bio: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments_ Oriental Fortune Network

Summary

[Anxu Bio: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments]Anxu Bio announced that with the outbreak of the new crown epidemic, the demand for instant detection reagents and detection instruments in various countries in the world has greatly increased. In particular, the foreign market demand is huge. The company plans to invest in the construction of in vitro diagnostic reagents and diagnostic instrument R&D and production projects, which will be implemented by a wholly-owned subsidiary, Xumin Biology, with an estimated total investment of 508 million yuan. (Financial Association)

　　Anxu Biologyannouncement, With the outbreak of the new crown epidemic, the demand for instant detection reagents and detection instruments in various countries around the world has greatly increased, especially in foreign markets. The company plans to invest in the construction of in vitro diagnostic reagents and diagnostic instrument R&D and production projects, which will be implemented by a wholly-owned subsidiary, Xumin Biology, with an estimated total investment of 508 million yuan. The company has raised a total of 597 million yuan, and plans to use part of the raised funds to invest in the project. After the project is completed, it will further expand the company’s production scale and improve the automation level of the production line.

(Article source: Financial Associated Press)

Article source: Financial Associated Press

Responsible editor: 98

Original title: Anxu Biology: It is planned to use the super-raised funds to invest in the R&D and production projects of in vitro diagnostic reagents and diagnostic instruments